tiprankstipranks
Trending News
More News >
Adial Pharmaceuticals Inc (ADIL)
NASDAQ:ADIL
US Market

Adial Pharmaceuticals (ADIL) Income Statement

Compare
601 Followers

Adial Pharmaceuticals Income Statement

Last quarter (Q3 2025), Adial Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Adial Pharmaceuticals's net income was $-1.79M. See Adial Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -564.00$ 0.00$ 0.00$ -564.00
Operating Expenses
$ 8.28M$ 6.89M$ 10.86M$ 19.29M$ 10.93M
Depreciation and Amortization
$ 565.00$ 564.00$ 564.00$ 55.11K$ 564.00
EBITDA
$ -8.28M$ -7.00M$ -10.86M$ -17.69M$ -10.93M
Operating Income
$ -8.28M$ -6.89M$ -10.86M$ -19.29M$ -10.93M
Other Income/Expenses
$ -4.91M$ -113.94K$ 63.34K$ -228.68K$ 34.99K
Pretax Income
$ -13.20M$ -7.00M$ -10.80M$ -19.52M$ -10.89M
Net Income
$ -13.20M$ -7.00M$ -12.73M$ -19.42M$ -10.86M
Per Share Metrics
Basic EPS
$ -0.71$ -5.44$ -11.98$ -26.12$ -21.79
Diluted EPS
$ -0.71$ -5.44$ -11.98$ -26.12$ -21.79
Weighted Average Shares Outstanding
18.59M 1.42M 1.06M 743.55K 498.52K
Weighted Average Shares Outstanding (Diluted)
18.59M 1.42M 1.06M 743.55K 498.52K
Currency in USD

Adial Pharmaceuticals Earnings and Revenue History